Literature DB >> 24055774

Development of a homogeneous assay for measurement of high-density lipoprotein-subclass cholesterol.

Yasuki Ito1, Noriyuki Satoh, Takayoshi Ishii, Junko Kumakura, Tsutomu Hirano.   

Abstract

BACKGROUND: Several studies have suggested that measurement of high-density lipoprotein (HDL) 2 and HDL3 subfractions might be more useful for evaluating coronary risk than total HDL-cholesterol (C). However, methods of measuring HDL2 and HDL3 are quite laborious for general clinical use. Development of a quick and easy method of measuring HDL subfractions has been long-awaited.
METHODS: Triglyceride (TG) rich lipoproteins (TRLs), low-density lipoprotein (LDL), HDL2, and HDL3 were used for screening of surfactants and enzymes to react selectively with HDL3-C and to decompose other lipoproteins.
RESULTS: In order to develop HDL3-C homogeneous assay, polyoxyethylene styrenated phenyl ether derivative, for which the hydrophilic lipophilic balance (HLB) value is 13.6, was adopted as the most effective and specific surfactant for selection of HDL3 from HDL. Sphingomyelinase (SMase) reacted with TRLs and LDL preferentially, and decomposed them. HDL2-C was estimated by subtracting measured HDL3-C from total HDL-C, directly measured by homogeneous method. The homogeneous assay exhibited excellent correlations with the results of HDL3-C and HDL2-C measured by standard ultracentrifugation (R(2)=0.848 and 0.982, respectively).
CONCLUSIONS: We established a rapid and effective, fully-automated assay for the measurement of HDL3-C. Furthermore, the subtraction of HDL3-C from total HDL-C allows concurrent determination of HDL2-C.
© 2013.

Entities:  

Keywords:  4-AA; 4-Aminoantipyrine; BES; DS; HDL subclasses; HDL3: HDL3-C; HLB; Hep–Mn; N,N-Bis(2-hydroxyethyl)-2-aminoethanesulfonic acid; N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline, sodium salt, dehydrate; SMase; Surfactant; TG rich lipoproteins; TOOS; TRLs; dextran sulfate; heparin–manganese; hydrophilic lipophilic balance; sphingomyelinase

Mesh:

Substances:

Year:  2013        PMID: 24055774     DOI: 10.1016/j.cca.2013.09.009

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Refocusing the AIM on HDL in the metabolic syndrome.

Authors:  Robert W McGarrah
Journal:  Atherosclerosis       Date:  2016-07-02       Impact factor: 5.162

2.  Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.

Authors:  John J Albers; April Slee; Jerome L Fleg; Kevin D O'Brien; Santica M Marcovina
Journal:  Atherosclerosis       Date:  2016-06-11       Impact factor: 5.162

3.  Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.

Authors:  Toshiyuki Hayashi; Tomoyasu Fukui; Noriko Nakanishi; Saki Yamamoto; Masako Tomoyasu; Anna Osamura; Makoto Ohara; Takeshi Yamamoto; Yasuki Ito; Tsutomu Hirano
Journal:  Cardiovasc Diabetol       Date:  2017-01-13       Impact factor: 9.951

4.  High-density lipoprotein 3 cholesterol is a predictive factor for arterial stiffness: a community-based 4.8-year prospective study.

Authors:  Fan Wang; Xiaona Wang; Ping Ye; Ruihua Cao; Yun Zhang; Yue Qi; Dong Zhao
Journal:  Lipids Health Dis       Date:  2018-01-05       Impact factor: 3.876

5.  HDL subclasses and mortality in acute heart failure patients.

Authors:  Vesna Degoricija; Ines Potočnjak; Michaela Gastrager; Gudrun Pregartner; Andrea Berghold; Hubert Scharnagl; Tatjana Stojakovic; Beate Tiran; Gunther Marsche; Saša Frank
Journal:  Clin Chim Acta       Date:  2018-12-19       Impact factor: 3.786

6.  Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan.

Authors:  Hung Hsu; Powen Hsu; Ming-Hui Cheng; Yasuki Ito; Eiichiro Kanda; Ernst J Schaefer; Masumi Ai
Journal:  J Atheroscler Thromb       Date:  2019-02-07       Impact factor: 4.928

Review 7.  Pathophysiology of Diabetic Dyslipidemia.

Authors:  Tsutomu Hirano
Journal:  J Atheroscler Thromb       Date:  2018-07-12       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.